Day 3 - Endo1 Glucose Metabolism Flashcards
NOT high-yield for step 2: Anti-islet antibodies seen in pts w/ diabetes
Review after step 2: anti-isulin, anti-islet cell cytoplasm, anti-glutamic acid decarboxylase, anti-tyrosine phosphatase
Distinguish somygi effect from dawn phenonmenon
Both cause high glucose levels upon waking in the AM; Somogyi effect - glucose too low in middle of night (e.g., evening NPH dose too high), stress hormone (e.g., catecholamines) aka counterregulatory hormones - boost glucose, Tx - decrease evening NPH, NPH at bedtime instead of dinner, snack before bedtime; Dawn phenomenon - because not take enough NPH, glucose never got low, Tx - increase evening NPH; Distinguish w/ 3 AM blood glucose check
DM agents - lactic acidosis as rare but worrisome side effect
Metformin
DM agents - most common side effect hypoglycemia
Sulfonylureas (also meglitinides)
DM agents - oldest and cheapest
Sulfonylureas
DM agents - often used in combo w/ any of other agents
Metformin (often 1st line)
DM agents - also help lower LDL and TG
Metformin
DM agents - Contraindicated in CHF
Thiazolidinediones (pioglitazone, rosiglitazone)
DM agents - not used in pts w/ elevated serum Cr
Metformin; Sulfonylureas
DM agents - not used in patients in IBD
Alpha-glucosidase inhibitors (acarbose); Note: mechanism to decrease GI absorption of starch & dissacharides
DM agents - hepatic serum transaminase levels must be carefully monitored
Metformin (also Thiazolidinediones - pioglitazone, rosiglitazone)
DM agents - not cause weight gain
Metformin
DM agents - metabolized by liver, excellent choice in patients with renal disease
Glitazones
DM agents - Primary affects postprandial glucose & taken w/ meals
Alpha-glucosidase inhibitors (acarbose)
DM agents - 3 newer drugs
(1) Exenatide (2) Sitagliptin (3) Pramlintide (see p. 113 in text) - Review details after step 2
If DM pt not controlled on 2 oral agents
Option 1 - add 3rd agent; Option 2 - add insulin
Should DM patient requiring insulin be on sulfonylurea
No, since sulfonylurea work by insulin release
Criteria for dx metabolic syndrome
3 of 5 following: (1) Abdominal/Truncal obesity (>40” in men or 35” in women) (2) TG > 150 (3) HDL 130/85 (prehypertension) (5) Fasting serum glucose > 100 (or 2 hours post orgal glucose challenge, glucose > 140, not 200)
Common causes of DKA
Excess glucagon, steroids, or catecholamines; Infx (pna, gastroenteritis, dka), severe medical illness (stroke, trauma), dehydration, alcohol/drug abuse, steroids
Necessary steps in tx DKA
Isotonic fluid boluses (LR preferred over NS, may be as much as 4L), 2x maintenance fluid (2:4:1 rule), IV Insulin (regular), identify/tx underlying cause, Replace K, likely replace Ca/Mg/Phos; Serum below 2-300, start IV glucose & continue IV insulin, check anion gap; Once anion gap normalizes, can return to normal insulin regimen
Dx ; Tx gastroparesis
Gastric emptying study (swallow barium, watch under fluoroscope in radiology; if not emptying stomach into duodenum); GI motility agents - Cisapride, erythromycin, metoclopramide
Meds not taken with cisapride due to risk of cardiac arrhythmias
Metabolized by same P450 - Macrolides (e.g., erythromycin), Antifungals, Phenothiazines (e.g., Prochloperazine or Chlorpromazine)
Standard care for DM pts
Exercising daily (proven to reduce mortality), Healthy diet, Daily blood glucose, Insulin (several times per day, if necessary), Physical exam every 3-6 mo [with attention to BP (avoid pre-HTN, 7,